Clinical Trials Directory

Trials / Terminated

TerminatedNCT03992183

Utility of CAML as Diagnostic for Early Stage Lung Cancer

TH-146: Cancer Associated Macrophage-Like (CAML) Cells to Enhance Detection of Early Stage Lung Cancer

Status
Terminated
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Fox Chase Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Primary Objective Determine the prevalence of CAMLS in patients with pulmonary nodules. Secondary Objectives Determine the positive and negative predictive value of CAMLS in patients with pulmonary nodules who undergo biopsy. Model combinations of clinical factors with the presence/absence of CAMLS to refine strategies for assessment of patients with pulmonary nodules. Evaluate whether these measures result in enhanced T-cell activity and/or NK cell function and number

Conditions

Timeline

Start date
2019-05-21
Primary completion
2022-11-14
Completion
2022-11-14
First posted
2019-06-20
Last updated
2026-03-04

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03992183. Inclusion in this directory is not an endorsement.